Global Antipyretic Medicine for Infants and Young Children Market Growth (Status and Outlook) 2026-2032
The global Antipyretic Medicine for Infants and Young Children market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Antipyretics are medicines that lower body temperature and relieve fever symptoms. Most antipyretics have other uses. For example, the most common antipyretics in the United States are usually ibuprofen and aspirin, which are nonsteroidal anti-inflammatory drugs that are mainly used as analgesics, but also have antipyretic effects. Because fever is part of the body's immune response, there is some controversy about the use of these drugs. Antipyretics for infants and young children need to be selected and used with extra caution because infants and young children are not yet fully developed and may be more sensitive to the drugs.
United States market for Antipyretic Medicine for Infants and Young Children is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antipyretic Medicine for Infants and Young Children is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antipyretic Medicine for Infants and Young Children is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antipyretic Medicine for Infants and Young Children players cover Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Antipyretic Medicine for Infants and Young Children Industry Forecast” looks at past sales and reviews total world Antipyretic Medicine for Infants and Young Children sales in 2025, providing a comprehensive analysis by region and market sector of projected Antipyretic Medicine for Infants and Young Children sales for 2026 through 2032. With Antipyretic Medicine for Infants and Young Children sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antipyretic Medicine for Infants and Young Children industry.
This Insight Report provides a comprehensive analysis of the global Antipyretic Medicine for Infants and Young Children landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antipyretic Medicine for Infants and Young Children portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antipyretic Medicine for Infants and Young Children market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antipyretic Medicine for Infants and Young Children and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antipyretic Medicine for Infants and Young Children.
This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Medicine for Infants and Young Children market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Antipyretics are medicines that lower body temperature and relieve fever symptoms. Most antipyretics have other uses. For example, the most common antipyretics in the United States are usually ibuprofen and aspirin, which are nonsteroidal anti-inflammatory drugs that are mainly used as analgesics, but also have antipyretic effects. Because fever is part of the body's immune response, there is some controversy about the use of these drugs. Antipyretics for infants and young children need to be selected and used with extra caution because infants and young children are not yet fully developed and may be more sensitive to the drugs.
United States market for Antipyretic Medicine for Infants and Young Children is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antipyretic Medicine for Infants and Young Children is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antipyretic Medicine for Infants and Young Children is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antipyretic Medicine for Infants and Young Children players cover Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Antipyretic Medicine for Infants and Young Children Industry Forecast” looks at past sales and reviews total world Antipyretic Medicine for Infants and Young Children sales in 2025, providing a comprehensive analysis by region and market sector of projected Antipyretic Medicine for Infants and Young Children sales for 2026 through 2032. With Antipyretic Medicine for Infants and Young Children sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antipyretic Medicine for Infants and Young Children industry.
This Insight Report provides a comprehensive analysis of the global Antipyretic Medicine for Infants and Young Children landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antipyretic Medicine for Infants and Young Children portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antipyretic Medicine for Infants and Young Children market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antipyretic Medicine for Infants and Young Children and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antipyretic Medicine for Infants and Young Children.
This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Medicine for Infants and Young Children market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Acetaminophen
- Ibuprofen
- Other
- Online Sales
- Offline Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Xinhua Pharmaceutical
- IOLCP
- Granules Biocause
- Strides Shasun
- Mallinckrodt
- Farmson
- Granules India
- SKPL
- Atabay
- Temad
- Anqiu Lu'an
- Zhejiang Kangle
- Hebei Jiheng
- Novacyl
- Anhui Fubore
- Anhui BBCA Likang
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
2.1.2 Antipyretic Medicine for Infants and Young Children Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Antipyretic Medicine for Infants and Young Children by Country/Region (2021, 2025 & 2032)
2.2 Antipyretic Medicine for Infants and Young Children Segment by Type
2.2.1 Acetaminophen
2.2.2 Ibuprofen
2.2.3 Other
2.2.4 Antipyretic Medicine for Infants and Young Children Market Size by Type
2.2.4.1 Antipyretic Medicine for Infants and Young Children Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
2.3 Antipyretic Medicine for Infants and Young Children Segment by Application
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Antipyretic Medicine for Infants and Young Children Market Size by Application
2.3.3.1 Antipyretic Medicine for Infants and Young Children Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
3 ANTIPYRETIC MEDICINE FOR INFANTS AND YOUNG CHILDREN MARKET SIZE BY PLAYER
3.1 Antipyretic Medicine for Infants and Young Children Market Size Market Share by Player
3.1.1 Global Antipyretic Medicine for Infants and Young Children Revenue by Player (2021-2026)
3.1.2 Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Player (2021-2026)
3.2 Global Antipyretic Medicine for Infants and Young Children Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIPYRETIC MEDICINE FOR INFANTS AND YOUNG CHILDREN BY REGION
4.1 Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026)
4.2 Global Antipyretic Medicine for Infants and Young Children Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
4.4 APAC Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
4.5 Europe Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
4.6 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
5.2 Americas Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
5.3 Americas Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026)
6.2 APAC Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
6.3 APAC Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
7.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
7.3 Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antipyretic Medicine for Infants and Young Children by Region (2021-2026)
8.2 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
8.3 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS AND YOUNG CHILDREN MARKET FORECAST
10.1 Global Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.1.1 Global Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.1.2 Americas Antipyretic Medicine for Infants and Young Children Forecast
10.1.3 APAC Antipyretic Medicine for Infants and Young Children Forecast
10.1.4 Europe Antipyretic Medicine for Infants and Young Children Forecast
10.1.5 Middle East & Africa Antipyretic Medicine for Infants and Young Children Forecast
10.2 Americas Antipyretic Medicine for Infants and Young Children Forecast by Country (2027-2032)
10.2.1 United States Market Antipyretic Medicine for Infants and Young Children Forecast
10.2.2 Canada Market Antipyretic Medicine for Infants and Young Children Forecast
10.2.3 Mexico Market Antipyretic Medicine for Infants and Young Children Forecast
10.2.4 Brazil Market Antipyretic Medicine for Infants and Young Children Forecast
10.3 APAC Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.3.1 China Antipyretic Medicine for Infants and Young Children Market Forecast
10.3.2 Japan Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.3 Korea Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.4 Southeast Asia Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.5 India Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.6 Australia Market Antipyretic Medicine for Infants and Young Children Forecast
10.4 Europe Antipyretic Medicine for Infants and Young Children Forecast by Country (2027-2032)
10.4.1 Germany Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.2 France Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.3 UK Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.4 Italy Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.5 Russia Market Antipyretic Medicine for Infants and Young Children Forecast
10.5 Middle East & Africa Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.5.1 Egypt Market Antipyretic Medicine for Infants and Young Children Forecast
10.5.2 South Africa Market Antipyretic Medicine for Infants and Young Children Forecast
10.5.3 Israel Market Antipyretic Medicine for Infants and Young Children Forecast
10.5.4 Turkey Market Antipyretic Medicine for Infants and Young Children Forecast
10.6 Global Antipyretic Medicine for Infants and Young Children Forecast by Type (2027-2032)
10.7 Global Antipyretic Medicine for Infants and Young Children Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Antipyretic Medicine for Infants and Young Children Forecast
11 KEY PLAYERS ANALYSIS
11.1 Xinhua Pharmaceutical
11.1.1 Xinhua Pharmaceutical Company Information
11.1.2 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Offered
11.1.3 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Xinhua Pharmaceutical Main Business Overview
11.1.5 Xinhua Pharmaceutical Latest Developments
11.2 IOLCP
11.2.1 IOLCP Company Information
11.2.2 IOLCP Antipyretic Medicine for Infants and Young Children Product Offered
11.2.3 IOLCP Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 IOLCP Main Business Overview
11.2.5 IOLCP Latest Developments
11.3 Granules Biocause
11.3.1 Granules Biocause Company Information
11.3.2 Granules Biocause Antipyretic Medicine for Infants and Young Children Product Offered
11.3.3 Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Granules Biocause Main Business Overview
11.3.5 Granules Biocause Latest Developments
11.4 Strides Shasun
11.4.1 Strides Shasun Company Information
11.4.2 Strides Shasun Antipyretic Medicine for Infants and Young Children Product Offered
11.4.3 Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Strides Shasun Main Business Overview
11.4.5 Strides Shasun Latest Developments
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Information
11.5.2 Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Offered
11.5.3 Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mallinckrodt Main Business Overview
11.5.5 Mallinckrodt Latest Developments
11.6 Farmson
11.6.1 Farmson Company Information
11.6.2 Farmson Antipyretic Medicine for Infants and Young Children Product Offered
11.6.3 Farmson Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Farmson Main Business Overview
11.6.5 Farmson Latest Developments
11.7 Granules India
11.7.1 Granules India Company Information
11.7.2 Granules India Antipyretic Medicine for Infants and Young Children Product Offered
11.7.3 Granules India Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Granules India Main Business Overview
11.7.5 Granules India Latest Developments
11.8 SKPL
11.8.1 SKPL Company Information
11.8.2 SKPL Antipyretic Medicine for Infants and Young Children Product Offered
11.8.3 SKPL Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 SKPL Main Business Overview
11.8.5 SKPL Latest Developments
11.9 Atabay
11.9.1 Atabay Company Information
11.9.2 Atabay Antipyretic Medicine for Infants and Young Children Product Offered
11.9.3 Atabay Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Atabay Main Business Overview
11.9.5 Atabay Latest Developments
11.10 Temad
11.10.1 Temad Company Information
11.10.2 Temad Antipyretic Medicine for Infants and Young Children Product Offered
11.10.3 Temad Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Temad Main Business Overview
11.10.5 Temad Latest Developments
11.11 Anqiu Lu'an
11.11.1 Anqiu Lu'an Company Information
11.11.2 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Offered
11.11.3 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Anqiu Lu'an Main Business Overview
11.11.5 Anqiu Lu'an Latest Developments
11.12 Zhejiang Kangle
11.12.1 Zhejiang Kangle Company Information
11.12.2 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Offered
11.12.3 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Zhejiang Kangle Main Business Overview
11.12.5 Zhejiang Kangle Latest Developments
11.13 Hebei Jiheng
11.13.1 Hebei Jiheng Company Information
11.13.2 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Offered
11.13.3 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Hebei Jiheng Main Business Overview
11.13.5 Hebei Jiheng Latest Developments
11.14 Novacyl
11.14.1 Novacyl Company Information
11.14.2 Novacyl Antipyretic Medicine for Infants and Young Children Product Offered
11.14.3 Novacyl Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Novacyl Main Business Overview
11.14.5 Novacyl Latest Developments
11.15 Anhui Fubore
11.15.1 Anhui Fubore Company Information
11.15.2 Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Offered
11.15.3 Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Anhui Fubore Main Business Overview
11.15.5 Anhui Fubore Latest Developments
11.16 Anhui BBCA Likang
11.16.1 Anhui BBCA Likang Company Information
11.16.2 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Offered
11.16.3 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Anhui BBCA Likang Main Business Overview
11.16.5 Anhui BBCA Likang Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
2.1.2 Antipyretic Medicine for Infants and Young Children Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Antipyretic Medicine for Infants and Young Children by Country/Region (2021, 2025 & 2032)
2.2 Antipyretic Medicine for Infants and Young Children Segment by Type
2.2.1 Acetaminophen
2.2.2 Ibuprofen
2.2.3 Other
2.2.4 Antipyretic Medicine for Infants and Young Children Market Size by Type
2.2.4.1 Antipyretic Medicine for Infants and Young Children Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
2.3 Antipyretic Medicine for Infants and Young Children Segment by Application
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Antipyretic Medicine for Infants and Young Children Market Size by Application
2.3.3.1 Antipyretic Medicine for Infants and Young Children Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
3 ANTIPYRETIC MEDICINE FOR INFANTS AND YOUNG CHILDREN MARKET SIZE BY PLAYER
3.1 Antipyretic Medicine for Infants and Young Children Market Size Market Share by Player
3.1.1 Global Antipyretic Medicine for Infants and Young Children Revenue by Player (2021-2026)
3.1.2 Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Player (2021-2026)
3.2 Global Antipyretic Medicine for Infants and Young Children Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIPYRETIC MEDICINE FOR INFANTS AND YOUNG CHILDREN BY REGION
4.1 Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026)
4.2 Global Antipyretic Medicine for Infants and Young Children Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
4.4 APAC Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
4.5 Europe Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
4.6 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
5.2 Americas Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
5.3 Americas Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026)
6.2 APAC Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
6.3 APAC Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
7.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
7.3 Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antipyretic Medicine for Infants and Young Children by Region (2021-2026)
8.2 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
8.3 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS AND YOUNG CHILDREN MARKET FORECAST
10.1 Global Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.1.1 Global Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.1.2 Americas Antipyretic Medicine for Infants and Young Children Forecast
10.1.3 APAC Antipyretic Medicine for Infants and Young Children Forecast
10.1.4 Europe Antipyretic Medicine for Infants and Young Children Forecast
10.1.5 Middle East & Africa Antipyretic Medicine for Infants and Young Children Forecast
10.2 Americas Antipyretic Medicine for Infants and Young Children Forecast by Country (2027-2032)
10.2.1 United States Market Antipyretic Medicine for Infants and Young Children Forecast
10.2.2 Canada Market Antipyretic Medicine for Infants and Young Children Forecast
10.2.3 Mexico Market Antipyretic Medicine for Infants and Young Children Forecast
10.2.4 Brazil Market Antipyretic Medicine for Infants and Young Children Forecast
10.3 APAC Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.3.1 China Antipyretic Medicine for Infants and Young Children Market Forecast
10.3.2 Japan Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.3 Korea Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.4 Southeast Asia Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.5 India Market Antipyretic Medicine for Infants and Young Children Forecast
10.3.6 Australia Market Antipyretic Medicine for Infants and Young Children Forecast
10.4 Europe Antipyretic Medicine for Infants and Young Children Forecast by Country (2027-2032)
10.4.1 Germany Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.2 France Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.3 UK Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.4 Italy Market Antipyretic Medicine for Infants and Young Children Forecast
10.4.5 Russia Market Antipyretic Medicine for Infants and Young Children Forecast
10.5 Middle East & Africa Antipyretic Medicine for Infants and Young Children Forecast by Region (2027-2032)
10.5.1 Egypt Market Antipyretic Medicine for Infants and Young Children Forecast
10.5.2 South Africa Market Antipyretic Medicine for Infants and Young Children Forecast
10.5.3 Israel Market Antipyretic Medicine for Infants and Young Children Forecast
10.5.4 Turkey Market Antipyretic Medicine for Infants and Young Children Forecast
10.6 Global Antipyretic Medicine for Infants and Young Children Forecast by Type (2027-2032)
10.7 Global Antipyretic Medicine for Infants and Young Children Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Antipyretic Medicine for Infants and Young Children Forecast
11 KEY PLAYERS ANALYSIS
11.1 Xinhua Pharmaceutical
11.1.1 Xinhua Pharmaceutical Company Information
11.1.2 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Offered
11.1.3 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Xinhua Pharmaceutical Main Business Overview
11.1.5 Xinhua Pharmaceutical Latest Developments
11.2 IOLCP
11.2.1 IOLCP Company Information
11.2.2 IOLCP Antipyretic Medicine for Infants and Young Children Product Offered
11.2.3 IOLCP Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 IOLCP Main Business Overview
11.2.5 IOLCP Latest Developments
11.3 Granules Biocause
11.3.1 Granules Biocause Company Information
11.3.2 Granules Biocause Antipyretic Medicine for Infants and Young Children Product Offered
11.3.3 Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Granules Biocause Main Business Overview
11.3.5 Granules Biocause Latest Developments
11.4 Strides Shasun
11.4.1 Strides Shasun Company Information
11.4.2 Strides Shasun Antipyretic Medicine for Infants and Young Children Product Offered
11.4.3 Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Strides Shasun Main Business Overview
11.4.5 Strides Shasun Latest Developments
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Information
11.5.2 Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Offered
11.5.3 Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mallinckrodt Main Business Overview
11.5.5 Mallinckrodt Latest Developments
11.6 Farmson
11.6.1 Farmson Company Information
11.6.2 Farmson Antipyretic Medicine for Infants and Young Children Product Offered
11.6.3 Farmson Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Farmson Main Business Overview
11.6.5 Farmson Latest Developments
11.7 Granules India
11.7.1 Granules India Company Information
11.7.2 Granules India Antipyretic Medicine for Infants and Young Children Product Offered
11.7.3 Granules India Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Granules India Main Business Overview
11.7.5 Granules India Latest Developments
11.8 SKPL
11.8.1 SKPL Company Information
11.8.2 SKPL Antipyretic Medicine for Infants and Young Children Product Offered
11.8.3 SKPL Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 SKPL Main Business Overview
11.8.5 SKPL Latest Developments
11.9 Atabay
11.9.1 Atabay Company Information
11.9.2 Atabay Antipyretic Medicine for Infants and Young Children Product Offered
11.9.3 Atabay Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Atabay Main Business Overview
11.9.5 Atabay Latest Developments
11.10 Temad
11.10.1 Temad Company Information
11.10.2 Temad Antipyretic Medicine for Infants and Young Children Product Offered
11.10.3 Temad Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Temad Main Business Overview
11.10.5 Temad Latest Developments
11.11 Anqiu Lu'an
11.11.1 Anqiu Lu'an Company Information
11.11.2 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Offered
11.11.3 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Anqiu Lu'an Main Business Overview
11.11.5 Anqiu Lu'an Latest Developments
11.12 Zhejiang Kangle
11.12.1 Zhejiang Kangle Company Information
11.12.2 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Offered
11.12.3 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Zhejiang Kangle Main Business Overview
11.12.5 Zhejiang Kangle Latest Developments
11.13 Hebei Jiheng
11.13.1 Hebei Jiheng Company Information
11.13.2 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Offered
11.13.3 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Hebei Jiheng Main Business Overview
11.13.5 Hebei Jiheng Latest Developments
11.14 Novacyl
11.14.1 Novacyl Company Information
11.14.2 Novacyl Antipyretic Medicine for Infants and Young Children Product Offered
11.14.3 Novacyl Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Novacyl Main Business Overview
11.14.5 Novacyl Latest Developments
11.15 Anhui Fubore
11.15.1 Anhui Fubore Company Information
11.15.2 Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Offered
11.15.3 Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Anhui Fubore Main Business Overview
11.15.5 Anhui Fubore Latest Developments
11.16 Anhui BBCA Likang
11.16.1 Anhui BBCA Likang Company Information
11.16.2 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Offered
11.16.3 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Anhui BBCA Likang Main Business Overview
11.16.5 Anhui BBCA Likang Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antipyretic Medicine for Infants and Young Children Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Antipyretic Medicine for Infants and Young Children Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acetaminophen
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Other
Table 6. Antipyretic Medicine for Infants and Young Children Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Table 9. Antipyretic Medicine for Infants and Young Children Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Table 12. Global Antipyretic Medicine for Infants and Young Children Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Player (2021-2026)
Table 14. Antipyretic Medicine for Infants and Young Children Key Players Head office and Products Offered
Table 15. Antipyretic Medicine for Infants and Young Children Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Table 20. Global Antipyretic Medicine for Infants and Young Children Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Antipyretic Medicine for Infants and Young Children Market Size Market Share by Country (2021-2026)
Table 24. Americas Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Table 26. Americas Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Table 28. APAC Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Table 30. APAC Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Country (2021-2026)
Table 34. Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antipyretic Medicine for Infants and Young Children
Table 40. Key Market Challenges & Risks of Antipyretic Medicine for Infants and Young Children
Table 41. Key Industry Trends of Antipyretic Medicine for Infants and Young Children
Table 42. Global Antipyretic Medicine for Infants and Young Children Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Antipyretic Medicine for Infants and Young Children Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Antipyretic Medicine for Infants and Young Children Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Xinhua Pharmaceutical Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 47. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Offered
Table 48. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Xinhua Pharmaceutical Main Business
Table 50. Xinhua Pharmaceutical Latest Developments
Table 51. IOLCP Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 52. IOLCP Antipyretic Medicine for Infants and Young Children Product Offered
Table 53. IOLCP Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. IOLCP Main Business
Table 55. IOLCP Latest Developments
Table 56. Granules Biocause Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 57. Granules Biocause Antipyretic Medicine for Infants and Young Children Product Offered
Table 58. Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Granules Biocause Main Business
Table 60. Granules Biocause Latest Developments
Table 61. Strides Shasun Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 62. Strides Shasun Antipyretic Medicine for Infants and Young Children Product Offered
Table 63. Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Strides Shasun Main Business
Table 65. Strides Shasun Latest Developments
Table 66. Mallinckrodt Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 67. Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Offered
Table 68. Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Mallinckrodt Main Business
Table 70. Mallinckrodt Latest Developments
Table 71. Farmson Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 72. Farmson Antipyretic Medicine for Infants and Young Children Product Offered
Table 73. Farmson Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Farmson Main Business
Table 75. Farmson Latest Developments
Table 76. Granules India Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 77. Granules India Antipyretic Medicine for Infants and Young Children Product Offered
Table 78. Granules India Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Granules India Main Business
Table 80. Granules India Latest Developments
Table 81. SKPL Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 82. SKPL Antipyretic Medicine for Infants and Young Children Product Offered
Table 83. SKPL Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. SKPL Main Business
Table 85. SKPL Latest Developments
Table 86. Atabay Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 87. Atabay Antipyretic Medicine for Infants and Young Children Product Offered
Table 88. Atabay Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Atabay Main Business
Table 90. Atabay Latest Developments
Table 91. Temad Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 92. Temad Antipyretic Medicine for Infants and Young Children Product Offered
Table 93. Temad Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Temad Main Business
Table 95. Temad Latest Developments
Table 96. Anqiu Lu'an Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 97. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Offered
Table 98. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Anqiu Lu'an Main Business
Table 100. Anqiu Lu'an Latest Developments
Table 101. Zhejiang Kangle Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 102. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Offered
Table 103. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Zhejiang Kangle Main Business
Table 105. Zhejiang Kangle Latest Developments
Table 106. Hebei Jiheng Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 107. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Offered
Table 108. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Hebei Jiheng Main Business
Table 110. Hebei Jiheng Latest Developments
Table 111. Novacyl Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 112. Novacyl Antipyretic Medicine for Infants and Young Children Product Offered
Table 113. Novacyl Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Novacyl Main Business
Table 115. Novacyl Latest Developments
Table 116. Anhui Fubore Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 117. Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Offered
Table 118. Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Anhui Fubore Main Business
Table 120. Anhui Fubore Latest Developments
Table 121. Anhui BBCA Likang Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 122. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Offered
Table 123. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Anhui BBCA Likang Main Business
Table 125. Anhui BBCA Likang Latest Developments
Table 1. Antipyretic Medicine for Infants and Young Children Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Antipyretic Medicine for Infants and Young Children Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acetaminophen
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Other
Table 6. Antipyretic Medicine for Infants and Young Children Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Table 9. Antipyretic Medicine for Infants and Young Children Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Table 12. Global Antipyretic Medicine for Infants and Young Children Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Player (2021-2026)
Table 14. Antipyretic Medicine for Infants and Young Children Key Players Head office and Products Offered
Table 15. Antipyretic Medicine for Infants and Young Children Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Table 20. Global Antipyretic Medicine for Infants and Young Children Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Antipyretic Medicine for Infants and Young Children Market Size Market Share by Country (2021-2026)
Table 24. Americas Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Table 26. Americas Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Table 28. APAC Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Table 30. APAC Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Country (2021-2026)
Table 34. Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antipyretic Medicine for Infants and Young Children
Table 40. Key Market Challenges & Risks of Antipyretic Medicine for Infants and Young Children
Table 41. Key Industry Trends of Antipyretic Medicine for Infants and Young Children
Table 42. Global Antipyretic Medicine for Infants and Young Children Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Antipyretic Medicine for Infants and Young Children Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Antipyretic Medicine for Infants and Young Children Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Xinhua Pharmaceutical Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 47. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Offered
Table 48. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Xinhua Pharmaceutical Main Business
Table 50. Xinhua Pharmaceutical Latest Developments
Table 51. IOLCP Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 52. IOLCP Antipyretic Medicine for Infants and Young Children Product Offered
Table 53. IOLCP Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. IOLCP Main Business
Table 55. IOLCP Latest Developments
Table 56. Granules Biocause Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 57. Granules Biocause Antipyretic Medicine for Infants and Young Children Product Offered
Table 58. Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Granules Biocause Main Business
Table 60. Granules Biocause Latest Developments
Table 61. Strides Shasun Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 62. Strides Shasun Antipyretic Medicine for Infants and Young Children Product Offered
Table 63. Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Strides Shasun Main Business
Table 65. Strides Shasun Latest Developments
Table 66. Mallinckrodt Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 67. Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Offered
Table 68. Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Mallinckrodt Main Business
Table 70. Mallinckrodt Latest Developments
Table 71. Farmson Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 72. Farmson Antipyretic Medicine for Infants and Young Children Product Offered
Table 73. Farmson Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Farmson Main Business
Table 75. Farmson Latest Developments
Table 76. Granules India Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 77. Granules India Antipyretic Medicine for Infants and Young Children Product Offered
Table 78. Granules India Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Granules India Main Business
Table 80. Granules India Latest Developments
Table 81. SKPL Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 82. SKPL Antipyretic Medicine for Infants and Young Children Product Offered
Table 83. SKPL Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. SKPL Main Business
Table 85. SKPL Latest Developments
Table 86. Atabay Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 87. Atabay Antipyretic Medicine for Infants and Young Children Product Offered
Table 88. Atabay Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Atabay Main Business
Table 90. Atabay Latest Developments
Table 91. Temad Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 92. Temad Antipyretic Medicine for Infants and Young Children Product Offered
Table 93. Temad Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Temad Main Business
Table 95. Temad Latest Developments
Table 96. Anqiu Lu'an Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 97. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Offered
Table 98. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Anqiu Lu'an Main Business
Table 100. Anqiu Lu'an Latest Developments
Table 101. Zhejiang Kangle Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 102. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Offered
Table 103. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Zhejiang Kangle Main Business
Table 105. Zhejiang Kangle Latest Developments
Table 106. Hebei Jiheng Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 107. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Offered
Table 108. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Hebei Jiheng Main Business
Table 110. Hebei Jiheng Latest Developments
Table 111. Novacyl Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 112. Novacyl Antipyretic Medicine for Infants and Young Children Product Offered
Table 113. Novacyl Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Novacyl Main Business
Table 115. Novacyl Latest Developments
Table 116. Anhui Fubore Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 117. Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Offered
Table 118. Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Anhui Fubore Main Business
Table 120. Anhui Fubore Latest Developments
Table 121. Anhui BBCA Likang Details, Company Type, Antipyretic Medicine for Infants and Young Children Area Served and Its Competitors
Table 122. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Offered
Table 123. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Anhui BBCA Likang Main Business
Table 125. Anhui BBCA Likang Latest Developments
LIST OF FIGURES
Figure 1. Antipyretic Medicine for Infants and Young Children Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Antipyretic Medicine for Infants and Young Children Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Antipyretic Medicine for Infants and Young Children Sales Market Share by Country/Region (2025)
Figure 8. Antipyretic Medicine for Infants and Young Children Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type in 2025
Figure 10. Antipyretic Medicine for Infants and Young Children in Online Sales
Figure 11. Global Antipyretic Medicine for Infants and Young Children Market: Online Sales (2021-2026) & ($ millions)
Figure 12. Antipyretic Medicine for Infants and Young Children in Offline Sales
Figure 13. Global Antipyretic Medicine for Infants and Young Children Market: Offline Sales (2021-2026) & ($ millions)
Figure 14. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application in 2025
Figure 15. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Player in 2025
Figure 16. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Figure 17. Americas Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 18. APAC Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 19. Europe Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 21. Americas Antipyretic Medicine for Infants and Young Children Value Market Share by Country in 2025
Figure 22. United States Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region in 2025
Figure 27. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Figure 28. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Figure 29. China Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 33. India Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Country in 2025
Figure 36. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Figure 37. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Figure 38. Germany Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 39. France Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 52. APAC Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 53. Europe Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 55. United States Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 56. Canada Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 57. Mexico Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 58. Brazil Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 59. China Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 60. Japan Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 61. Korea Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 63. India Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 64. Australia Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 65. Germany Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 66. France Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 67. UK Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 68. Italy Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 69. Russia Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 70. Egypt Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 71. South Africa Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 72. Israel Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 73. Turkey Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 74. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 1. Antipyretic Medicine for Infants and Young Children Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Antipyretic Medicine for Infants and Young Children Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Antipyretic Medicine for Infants and Young Children Sales Market Share by Country/Region (2025)
Figure 8. Antipyretic Medicine for Infants and Young Children Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type in 2025
Figure 10. Antipyretic Medicine for Infants and Young Children in Online Sales
Figure 11. Global Antipyretic Medicine for Infants and Young Children Market: Online Sales (2021-2026) & ($ millions)
Figure 12. Antipyretic Medicine for Infants and Young Children in Offline Sales
Figure 13. Global Antipyretic Medicine for Infants and Young Children Market: Offline Sales (2021-2026) & ($ millions)
Figure 14. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application in 2025
Figure 15. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Player in 2025
Figure 16. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Figure 17. Americas Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 18. APAC Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 19. Europe Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size 2021-2026 ($ millions)
Figure 21. Americas Antipyretic Medicine for Infants and Young Children Value Market Share by Country in 2025
Figure 22. United States Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region in 2025
Figure 27. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Figure 28. APAC Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Figure 29. China Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 33. India Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Country in 2025
Figure 36. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Figure 37. Europe Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Figure 38. Germany Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 39. France Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Antipyretic Medicine for Infants and Young Children Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 52. APAC Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 53. Europe Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 55. United States Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 56. Canada Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 57. Mexico Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 58. Brazil Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 59. China Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 60. Japan Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 61. Korea Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 63. India Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 64. Australia Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 65. Germany Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 66. France Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 67. UK Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 68. Italy Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 69. Russia Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 70. Egypt Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 71. South Africa Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 72. Israel Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 73. Turkey Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
Figure 74. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Antipyretic Medicine for Infants and Young Children Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Antipyretic Medicine for Infants and Young Children Market Size 2027-2032 ($ millions)
